Rena M Conti

7PUBLICATIONS
13CO-AUTHORS
Industrial molecular engineering of nucleic acids and proteinsSerious gamesHaematological tumoursPharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 06, 2026
An evaluation of the US public-private Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) initiative.

|Feb 25, 2026
Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study.

T Joseph Mattingly, Emeka Elvis Duru, Rena M Conti

|Jun 03, 2025
Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD).

Rena M Conti, Shaylene McCue, Travis Dockter

|Dec 04, 2024
Predicting the next round of drugs for Medicare price negotiation.

Matthew Vogel, Adam Tellier, Rena M Conti

|Jan 31, 2024
Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act.

Matthew Vogel, Pragya Kakani, Amitabh Chandra

|Nov 07, 2023
The estimated annual financial impact of gene therapy in the United States.

Chi Heem Wong, Dexin Li, Nina Wang

Pageof 2

Frequent Collaborators

2 joint publications

Matthew Vogel

1 joint publications

Shaylene McCue

1 joint publications

Travis Dockter

1 joint publications

Heather Gunn